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Background: Chronic heart failure (CHF) is the final stage of the cardiovascular diseases, and is related with high mortality and poor prognosis. 
ASV is a novel therapy for congestive heart failure patients with sleep-disordered breathing. The ASV device provides automatically adjusted 
inspiratory pressure support for each breath, and is usually set at low level of end-expiratory pressure. The aim of this study was to investigate the 
effectiveness of ASV at remote phase for patients with advanced chronic heart failure.
Methods: Thirty-five patients (mean age; 73, 19 male) with CHF (NYHA functional class ; III and IV) and LV systolic dysfunction (LVEF<45%) were 
enrolled for ASV therapy. All patients were treated with optical medical therapy for at least 1 month. The patients were divided into two groups: ASV 
group (n=21) who continued the treatment and Withdrawal group (n=14). CHF-related parameters were measured at 6 month after ASV treatment.
Results: Admission-free survival was significantly greater in ASV group than in Withdrawal group (p<0.001, logrank test; Figure). The improvements 
in left ventricular ejection fraction was greater in the ASV group (p=0.0121). Multivariate regression analysis showed that ASV therapy was an 
independent predictor for re-hospitalization (p=0.0232).
Conclusions: ASV therapy improved left ventricular function, and therefore, the prognosis of CHF patients and contributed to a reduced risk of 
re-hospitalization in these patients.
 
